Teva Pharmaceutical Industries Limited (TEVA) financial statements (2021 and earlier)

Company profile

Business Address 5 BAZEL ST
PETACH TIKVA, 49131
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,1771,9751,782963
Cash and cash equivalents2,1771,9751,782963
Receivables4,5815,6765,8227,927
Inventory, net of allowances, customer advances and progress billings4,4034,4224,7314,924
Inventory4,4034,4224,7314,924
Prepaid expense945870899 
Disposal group, including discontinued operation1898792 
Other current assets710434468 
Other undisclosed current assets   1,568
Total current assets:13,00513,46413,79415,382
Noncurrent Assets
Finance lease, right-of-use asset 37
Operating lease, right-of-use asset559514
Property, plant and equipment6,2966,4366,8687,673
Intangible assets, net (including goodwill)29,54736,07838,92246,054
Goodwill20,62424,84624,91728,414
Intangible assets, net (excluding goodwill)8,92311,23214,00517,640
Deferred income tax assets695 
Other noncurrent assets538591731932
Deferred tax assets, net (2,703)
Other undisclosed noncurrent assets 3503683,277
Total noncurrent assets:37,63544,00646,88955,233
TOTAL ASSETS:50,64057,47060,68370,615
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,4411,7181,8532,069
Accounts payable1,756   
Employee-related liabilities685693870 
Other undisclosed accounts payable and accrued liabilities 1,0259832,069
Debt3,1882,3452,2163,646
Other liabilities933889804724
Other undisclosed current liabilities6,6028,7229,44911,482
Total current liabilities:13,16413,67414,32217,921
Noncurrent Liabilities
Long-term debt and lease obligation23,21024,99726,70028,829
Long-term debt, excluding current maturities22,73124,56226,70028,829
Operating lease, liability479435
Liabilities, other than long-term debt2,2402,6403,8675,120
Deferred tax liabilities, net2,1403,277
Other liabilities2,2402,6401,7271,843
Other undisclosed noncurrent liabilities9641,096  
Total noncurrent liabilities:26,41428,73330,56733,949
Other undisclosed liabilities1   
Total liabilities:39,57942,40744,88951,870
Stockholders' equity
Stockholders' equity attributable to parent, including:10,02613,97214,70717,359
Preferred stock   3,631
Common stock57565654
Treasury stock, value(4,128)(4,128)(4,142)(4,149)
Additional paid in capital27,44327,31227,21023,479
Accumulated other comprehensive loss(2,399)(2,312)(2,459)(1,853)
Accumulated deficit(10,946)(6,956)(5,958)(3,803)
Other undisclosed stockholders' equity attributable to parent(1)   
Stockholders' equity attributable to noncontrolling interest1,0351,0911,0871,386
Total stockholders' equity:11,06115,06315,79418,745
TOTAL LIABILITIES AND EQUITY:50,64057,47060,68370,615

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues16,65916,88718,85423,584
Revenue, net22,385
Cost of revenue
(Cost of Goods and Services Sold)
(8,933)(9,351)(10,558)(11,560)
Other undisclosed gross profit 1 (1,199)
Gross profit:7,7267,5378,29610,825
Operating expenses(4,668)(4,816)(4,147)(4,986)
Other operating income, net4076  
Other undisclosed operating loss(6,670)(3,240)(5,786)(23,323)
Operating loss:(3,572)(443)(1,637)(17,484)
Nonoperating expense(834)(822)(959)(895)
Interest and debt expense(963)(881)(920)(875)
Other undisclosed income from continuing operations before equity method investments, income taxes963881920875
Loss from continuing operations before equity method investments, income taxes:(4,406)(1,265)(2,596)(18,379)
Income (loss) from equity method investments138(13)(71)(3)
Loss from continuing operations before income taxes:(4,268)(1,278)(2,667)(18,382)
Income tax benefit1682781951,933
Loss before gain (loss) on sale of properties:(4,100)(1,000)(2,472)(16,449)
Other undisclosed net income1   
Net loss:(4,099)(1,000)(2,472)(16,449)
Net income attributable to noncontrolling interest1092322184
Other undisclosed net loss attributable to parent (1)  
Net loss attributable to parent:(3,990)(999)(2,150)(16,265)
Preferred stock dividends and other adjustments  (249)(260)
Net loss available to common stockholders, diluted:(3,990)(999)(2,399)(16,525)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(4,099)(1,000)(2,472)(16,449)
Other comprehensive income (loss)(30)160(585)1,306
Other undisclosed comprehensive income   184
Comprehensive loss:(4,129)(840)(3,057)(14,959)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest53(12)296184
Other undisclosed comprehensive loss, net of tax, attributable to parent   (305)
Comprehensive loss, net of tax, attributable to parent:(4,076)(852)(2,761)(15,080)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: